kabutan

Pharmarise Holdings, Jun-Feb (Cumulative 3Q) Ordinary Profit Turns to Profit, Dec-Feb Ordinary Profit Turns to Profit

Thu Mar 19, 2026 5:00 pm JST Earnings

2796 Pharmarise Holdings Corporation 【J-GAAP】

Earnings Report

Pharmarise Holdings Corporation <2796> [TSE Std] announced its financial results after the market closed on March 19th (17:00). The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending May 2026 (June 2025 to February 2026) turned into a profit of 419 million yen (compared to a loss of 18 million yen in the same period last year). However, Progress toward the full-year plan of 941 million yen was 44.5%, also falling below the five-year average of 68.1%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the March to May period (4Q) is expected to surge 3.4 times that of the same period last year, reaching 522 million yen.

In the most recent three-month period, from December to February (3Q), the consolidated ordinary profit/loss turned to a profit of 91 million yen (compared to a loss of 47 million yen in the same period last year). The operating profit/loss margin improved from -0.0% in the same period last year to 1.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jun - Feb, 2023 40,674 863 799 177 17.2 95.9 Mar 25, 2024 J-GAAP
Jun - Feb, 2024 46,579 95 -18 -272 -24.1 ー Mar 25, 2025 J-GAAP
Jun - Feb, 2025 50,556 603 419 -13 -1.2 44.5 Mar 19, 2026 J-GAAP
YoY +8.5% +534.7% － +95.2% +95.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec - May, 2024 32,964 193 107 -254 -22.5 14 Jun 25, 2025 J-GAAP
Dec - May, 2025 Guidance 33,193 724 613 155 13.5 14 Dec 25, 2025 J-GAAP
YoY +0.7% +275.1% +472.9% － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
May, 2024 54,466 916 833 -351 -33.4 20 Jun 28, 2024 J-GAAP
May, 2025 63,508 293 136 -367 -32.5 14 Jun 25, 2025 J-GAAP
May, 2026 Guidance 66,795 1,123 941 266 23.1 14 Jun 25, 2025 J-GAAP
YoY +5.2% +283.3% +591.9% － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Dec - Feb, 2024 16,035 -5 -47 -159 -14.1 0.0 Mar 25, 2025 J-GAAP
Mar - May, 2025 16,929 198 154 -95 -8.4 1.2 Jun 25, 2025 J-GAAP
Jun - Aug, 2025 16,753 152 115 -18 -1.6 0.9 Sep 25, 2025 J-GAAP
Sep - Nov, 2025 16,849 247 213 129 11.3 1.5 Dec 25, 2025 J-GAAP
Dec - Feb, 2025 16,954 204 91 -124 -11.5 1.2 Mar 19, 2026 J-GAAP
YoY +5.7% － － +22.0% +18.6%

Related Articles